Cleocin (clindamycin phosphate)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved March 1998

Specific Treatments:

bacterial vaginosis

General Information

A three-day treatment option for Cleocin Vaginal Cream 2% has been approved for the treatment of bacterial vaginosis in non-pregnant women. Cleocin Vaginal Cream was first marketed in the U.S. in 1992, as a seven-day course therapy. Along with approval of the three-day therapy option, the FDA has also added pregnant women in their third trimester to the population who can be treated with the seven-day treatment option.

Available only by prescription, Cleocin Vaginal Cream three-day treatment option comes in a new 21-gram tube with three disposable applicators.